MEKanistic Therapeutics, a biotechnology company developing first-in-class precision medicines designed to overcome cancer resistance mechanisms, today announced that the U.S. Food and Drug ...
The research details how neurons and glial cells utilize leucine-derived acetyl-coenzyme A (AcCoA) rather than canonical ...
Osteoporosis is a common bone metabolic disorder characterized by reduced bone mass and deterioration of bone ...
Acute myeloid leukemia (AML) is a multifaceted and devastating blood cancer characterized by frequent genetic mutations, ...
Evexomostat combination shows clinical benefit and favorable safety in heavily pretreated HR+/HER2− mBC patients with ...
Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research ...
Cancer immunotherapy has entered a transformative era, providing durable benefits to many patients. However, a substantial subset of malignancies remains ...
AI-driven genomic analysis could help researchers identify existing drugs that may be repurposed for subtype-specific breast ...
Planned Enrollment to Increase from 12 to 36 Patients Following Continued Encouraging Safety and Tolerability Data ...
Planned Enrollment to Increase from 12 to 36 Patients Following Continued Encouraging Safety and Tolerability Data SYDNEY, May 26, 2026 /PRNewswire/ -- Kazia Therapeutics ...
The Hearty Soul on MSN
Chronic condition linked to raised breast and ovarian cancer risks
New 2026 research links endometriosis to elevated ovarian and breast cancer risks. Here's what the science says and what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results